quinazolines has been researched along with Constitutional Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunt, CM; Spraggs, CF; Xu, CF | 1 |
| Dollery, CT; Hunt, CM; Parham, LR; Spraggs, CF | 1 |
1 review(s) available for quinazolines and Constitutional Liver Dysfunction
| Article | Year |
|---|---|
Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors.
Topics: Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Gilbert Disease; Glucuronosyltransferase; Humans; Indazoles; Lapatinib; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Sulfonamides | 2013 |
1 trial(s) available for quinazolines and Constitutional Liver Dysfunction
| Article | Year |
|---|---|
Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes.
Topics: Alanine Transaminase; Chemical and Drug Induced Liver Injury; Genotype; Gilbert Disease; Glucuronosyltransferase; HLA-DQ alpha-Chains; HLA-DRB1 Chains; Humans; Incidence; Lapatinib; Quinazolines | 2012 |